Abstract
Repair of damaged DNA is essential for maintaining genome integrity and for preventing genome-instability-associated diseases, such as cancer. By combining proximity labeling with quantitative mass spectrometry, we generated high-resolution interaction neighborhood maps of the endogenously expressed DNA repair factors 53BP1, BRCA1, and MDC1. Our spatially resolved interaction maps reveal rich network intricacies, identify shared and bait-specific interaction modules, and implicate previously concealed regulators in this process. We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins, RINN1 (CTC-534A2.2), RINN2 (FAM35A), and RINN3 (C20ORF196). Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis, promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres. Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection and in sensitizing BRCA1-deficient cells to PARP inhibitors. These findings have implications for understanding cancer-associated PARPi resistance and the evolution of antibody CSR in higher vertebrates.
Keywords:
53BP1; BRCA1; DNA damage repair; NHEJ; PARP inhibitors; antibody class-switch recombination; proteomics; proximity labeling; shieldin; telomere maintenance.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Intramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Adaptor Proteins, Signal Transducing
-
BRCA1 Protein / antagonists & inhibitors
-
BRCA1 Protein / genetics
-
BRCA1 Protein / metabolism
-
Cell Cycle Proteins
-
Cell Line, Tumor
-
DNA Breaks, Double-Stranded
-
DNA End-Joining Repair / drug effects*
-
DNA-Binding Proteins / antagonists & inhibitors
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism*
-
Humans
-
Immunoglobulin Class Switching / drug effects
-
Mad2 Proteins / antagonists & inhibitors
-
Mad2 Proteins / genetics
-
Mad2 Proteins / metabolism
-
Mutagenesis, Site-Directed
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism
-
Poly(ADP-ribose) Polymerase Inhibitors / pharmacology*
-
RNA Interference
-
RNA, Small Interfering / metabolism
-
Telomere-Binding Proteins / antagonists & inhibitors
-
Telomere-Binding Proteins / genetics
-
Telomere-Binding Proteins / metabolism
-
Trans-Activators / genetics
-
Trans-Activators / metabolism
-
Tumor Suppressor p53-Binding Protein 1 / antagonists & inhibitors
-
Tumor Suppressor p53-Binding Protein 1 / genetics
-
Tumor Suppressor p53-Binding Protein 1 / metabolism
-
Ubiquitin-Protein Ligases / antagonists & inhibitors
-
Ubiquitin-Protein Ligases / genetics
-
Ubiquitin-Protein Ligases / metabolism
Substances
-
Adaptor Proteins, Signal Transducing
-
BRCA1 Protein
-
BRCA1 protein, human
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
MAD2L2 protein, human
-
MDC1 protein, human
-
Mad2 Proteins
-
Nuclear Proteins
-
Poly(ADP-ribose) Polymerase Inhibitors
-
RNA, Small Interfering
-
RNF8 protein, human
-
Rif1 protein, human
-
TP53BP1 protein, human
-
Telomere-Binding Proteins
-
Trans-Activators
-
Tumor Suppressor p53-Binding Protein 1
-
Ubiquitin-Protein Ligases